skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Potential role of stem cells in management of COPD

Review

(3783) Views  (1264) Full article downloads

Authors: Tillie L Hackett, Darryl A Knight, Don D Sin

Published Date March 2010 Volume 2010:5 Pages 81 - 88
DOI: http://dx.doi.org/10.2147/COPD.S7373

Tillie L Hackett1,2, Darryl A Knight1,2, Don D Sin1,3

1UBC James Hogg Research Centre, Heart and Lung Institute, St Paul’s Hospital, Vancouver, BC, Canada, V6Z 1Y6; 2Department of Anesthesiology, Pharmacology and Therapeutics, 3Department of Medicine, University of British Columbia, Vancouver, BC Canada

Abstract: Chronic obstructive pulmonary disease (COPD) is a worldwide epidemic affecting over 200 million people and accounting for more than three million deaths annually. The disease is characterized by chronic inflammation of the airways and progressive destruction of lung parenchyma, a process that in most cases is initiated by cigarette smoking. Unfortunately, there are no interventions that have been unequivocally shown to prolong survival in patients with COPD. Regeneration of lung tissue by stem cells from endogenous and exogenous sources is a promising therapeutic strategy. Herein we review the current literature on the characterization of resident stem and progenitor cell niches within the lung, the contribution of mesenchymal stem cells to lung regeneration, and advances in bioengineering of lung tissue.

Keywords: COPD, stem cell therapy, epithelial repair, regenerative medicine






 

Other articles by Dr Don Sin



Readers of this article also read:

Fat-free mass change after nutritional rehabilitation in weight losing COPD: role of insulin, C-reactive protein and tissue hypoxia
Preventing and managing exacerbations in COPD – critical appraisal of the role of tiotropium
Impact of bronchodilator therapy on exercise tolerance in COPD
Health care utilization history, GOLD guidelines, and respiratory medication prescriptions in patients with COPD
Cost-effectiveness of combination fluticasone propionate–salmeterol 250/50 μg versus salmeterol in severe COPD patients
Efficacy and safety of tiotropium Respimat® SMI in COPD in two 1-year randomized studies
An overview of the benefits and drawbacks of inhaled corticosteroids in chronic obstructive pulmonary disease
Changes in six-minute walking distance during pulmonary rehabilitation in patients with COPD and in healthy subjects
Onset of action of indacaterol in patients with COPD: Comparison with salbutamol and salmeterol-fluticasone
Unicentric study of cell therapy in chronic obstructive pulmonary disease/pulmonary emphysema
  • Journal Indexing

    See where all the Dove Press journals are indexed

  • Testimonials

    "You do a tremendous job!!" Ruben Restrepo, The University of Texas Health Science Center at San Antonio